Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic - Reza Yaesoubi, Joshua Havumaki, Melanie H. Chitwood, Nicolas A. Menzies, Gregg Gonsalves, Joshua A.
When cost-effective interventions are unaffordable: Integrating cost- effectiveness and budget impact in priority setting for global health programs | PLOS Medicine
PDF) When cost-effective interventions are unaffordable: Integrating cost- effectiveness and budget impact in priority setting for global health programs
Joshua Salomon (@SalomonJA) / Twitter
Passing the Test: A Model-based analysis of safe school-reopening strategies
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health
When cost-effective interventions are unaffordable: Integrating cost- effectiveness and budget impact in priority setting for global health programs | PLOS Medicine
40th Annual Meeting of the Society for Medical Decision Making Montréal, Québec, Canada, October 13–17, 2018, 2019
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis. - Abstract - Europe PMC
Balancing health and financial protection in health benefit package design - Lofgren - - Health Economics - Wiley Online Library
A Stress Test for America's New COVID Plan Is Coming - The Atlantic
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health
Hoover Fellows
Joshua Salomon – Prevention Policy Modeling Lab
Future Directions for Cost-effectiveness Analyses in Health and Medicine
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. - Abstract - Europe PMC
39th Annual Meeting of the Society for Medical Decision Making Pittsburgh, Pennsylvania, October 22-25, 2017, 2018
FSI | SHP - Joshua Salomon
PDF) Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China
Covid News: White House Promises More Covid Treatments - The New York Times
When cost-effective interventions are unaffordable: Integrating cost- effectiveness and budget impact in priority setting for global health programs | PLOS Medicine
Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study | BMJ Open
